Detalhe da pesquisa
1.
Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.
EClinicalMedicine
; 23: 100353, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639485